Q2 2020

Source filing unavailable

Q2 2020 · —

Revenue

$62.14B

+2.5% vs Q2 2019

Net Income

$6.64B

+101.5% vs Q2 2019

EPS Diluted

$6.91

+102.0% vs Q2 2019

Operating Income$9,241,000,000+94.8%

Operating Cash Flowderived$10,003,000,000+70.3%

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2018	Q2 2017
Revenue	$62.14B	$60.60B	$56.09B	$50.05B
Net Income	$6.64B	$3.29B	$2.92B	$2.28B
EPS Diluted	$6.91	$3.42	$2.98	$2.32

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

UnitedHealth Group Inc · CIK 731766 · Engraved from SEC EDGAR